Cargando…
Investigating p62 Concentrations in Cerebrospinal Fluid of Patients with Dementia: A Potential Autophagy Biomarker In Vivo?
Several studies have revealed defects in autophagy in neurodegenerative disorders including Alzheimer’s disease (AD) and frontotemporal dementia (FTD). SQSTM1/p62 plays a key role in the autophagic machinery and may serve as a marker for autophagic flux in vivo. We investigated the role of p62 in ne...
Autores principales: | Rubino, Elisa, Boschi, Silvia, Roveta, Fausto, Marcinnò, Andrea, Cermelli, Aurora, Borghese, Cristina, Vigliani, Maria Claudia, Rainero, Innocenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599226/ https://www.ncbi.nlm.nih.gov/pubmed/36291347 http://dx.doi.org/10.3390/brainsci12101414 |
Ejemplares similares
-
Aβ42 as a Biomarker of Alzheimer’s Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?
por: Boschi, Silvia, et al.
Publicado: (2022) -
Increased orexin A concentrations in cerebrospinal fluid of patients with behavioural variant frontotemporal dementia
por: Roveta, Fausto, et al.
Publicado: (2021) -
Impact of COVID-19 on chronic migraine treated with erenumab: a case report
por: Grassini, Alberto, et al.
Publicado: (2021) -
Decreased resistin plasmatic concentrations in patients with Alzheimer's disease: A case-control study
por: Marcinnò, Andrea, et al.
Publicado: (2022) -
Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks
por: Rubino, Elisa, et al.
Publicado: (2022)